Abstract
Background: Mutations in LRRK2 are among the most frequent genetic changes identified in Parkinson's disease (PD), but how LRRK2 contributes to the pathophysiology of PD is not known. Objectives: To investigate how expressing wild-type or G2019S LRRK2 modifies cellular responses to rotenone, a mitochondrial toxin. Methods: We investigated the vulnerability to mitochondrial toxins in Caenorhabditis elegans expressing wild-type or G2019S LRRK2. Results: We observed a powerful role for LRRK2 in mitochondrial biology. Overexpressing LRRK2 strongly protects C. elegans against rotenone toxicity. The G2019S LRRK2 construct also protected LRRK2 against rotenone, but to a lesser degree than wild-type LRRK2. Knockdown of lrk-1 potentiated rotenone toxicity. Conclusions: These data suggest that LRRK1/2 regulate mitochondrial physiology. Copyright © 2008 S. Karger AG.
Author supplied keywords
Cite
CITATION STYLE
Wolozin, B., Saha, S., Guillily, M., Ferree, A., & Riley, M. (2008). Investigating convergent actions of genes linked to familial Parkinson’s disease. In Neurodegenerative Diseases (Vol. 5, pp. 182–185). https://doi.org/10.1159/000113697
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.